LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 636 | 4012 | 0.1589 | -0.3108 |
MDA-MB-231 | A443654 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 525 | 4405 | 0.1199 | -0.3748 |
MCF7 | A443654 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 631 | 4012 | 0.1570 | -0.3152 |
MCF7 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 874 | 4012 | 0.2179 | -0.1724 |
MDA-MB-231 | A443654 | 10 | uM | LJP6 | 72 | hr | 1235 | 344 | 4405 | 0.0782 | -0.5024 |
SK-BR-3 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1401 | 1287 | 4168 | 0.3092 | -0.0525 |
MCF7 | A443654 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 491 | 4012 | 0.1226 | -0.4072 |
MDA-MB-231 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 414 | 4405 | 0.0940 | -0.4497 |
MCF7 | A443654 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1361 | 4012 | 0.3394 | 0.0696 |
Hs 578T | A443654 | 1.11 | uM | LJP6 | 72 | hr | 658 | 308 | 3761 | 0.0819 | -0.2618 |
Hs 578T | A443654 | 3.33 | uM | LJP6 | 72 | hr | 658 | 294 | 3761 | 0.0781 | -0.2747 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2739 | 4405 | 0.6225 | 0.5442 |
BT-20 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3152 | 3673 | 0.8581 | 0.8317 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2749 | 4405 | 0.6241 | 0.5463 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1235 | 628 | 4405 | 0.1427 | -0.3090 |
BT-20 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3253 | 3673 | 0.8856 | 0.8654 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4254 | 4405 | 0.9654 | 0.9608 |
BT-20 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3032 | 3673 | 0.8258 | 0.7919 |
BT-20 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3081 | 3673 | 0.8390 | 0.8076 |
BT-20 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1097 | 816 | 3673 | 0.2224 | -0.1564 |
SK-BR-3 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1401 | 1550 | 4168 | 0.3716 | 0.0641 |
MCF7 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1209 | 922 | 4012 | 0.2304 | -0.1451 |
SK-BR-3 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1401 | 1223 | 4168 | 0.2935 | -0.0830 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3665 | 4012 | 0.9147 | 0.9003 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3666 | 4012 | 0.9160 | 0.9019 |